Giorgio Cameli

Evaluation of Pyrazolone-Based Hydrazones as Potential Therapeutic Agents Against Glioblastoma

Background: Glioblastoma (GBM) is the most aggressive subtype of malignant glioma. Current therapeutic options remain limited, highlighting the need for the development of novel compounds capable of improving the efficacy of standard treatments. This study aimed to evaluate the b...